Clinical Trial Update: The Biodistribution of 1-[2 Deoxy-2, -18 Fluroarabinfuranosyl]Cytosine [18FAC] in Healthy Subjects and Patients With Cancer, Autoimmune/Inflammatory Diseases

View source ↗

Summary

A completed trial evaluating the biodistribution of the radiolabeled compound 18F-FAC in healthy volunteers and patients with cancer and inflammatory/autoimmune…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Diseases
• Cancer
• Inflammatory Diseases

Drugs mentioned

• 18F-FAC

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Cancer, Inflammation | Status: COMPLETED